Literature DB >> 18819798

Fluorination of mammalian cell surfaces via the sialic acid biosynthetic pathway.

Laila Dafik1, Marc d'Alarcao, Krishna Kumar.   

Abstract

Metabolic oligosaccharide engineering has been employed to introduce fluorine-containing groups onto mammalian cell surfaces. Incubation of HeLa, Jurkat, and HL60 cells in culture with fluorinated sialic acid and mannosamine analogues resulted in cell-surface presentation of fluorinated glycans. Metabolic conversion of fluorinated precursors was detected and quantified by DMB-derivatization and HPLC ESI-MS analysis. Between 7% and 72% of total membrane-associated sialosides were fluorinated, depending on the precursor used and the cell type. Fluorination of mammalian cell surfaces provides a means for introducing a bioorthogonal surface for modulating noncovalent interactions such as those involved in cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819798      PMCID: PMC2702668          DOI: 10.1016/j.bmcl.2008.09.010

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

1.  Engineering the sialic acid in organs of mice using N-propanoylmannosamine.

Authors:  Daniel Gagiannis; Reinhart Gossrau; Werner Reutter; Martin Zimmermann-Kordmann; Rüdiger Horstkorte
Journal:  Biochim Biophys Acta       Date:  2006-10-06

Review 2.  Bioorthogonal noncovalent chemistry: Fluorous phases in chemical biology.

Authors:  Nicholas C Yoder; Deniz Yüksel; Laila Dafik; Krishna Kumar
Journal:  Curr Opin Chem Biol       Date:  2006-10-19       Impact factor: 8.822

Review 3.  Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer.

Authors:  R Kannagi
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses.

Authors:  O T Keppler; P Stehling; M Herrmann; H Kayser; D Grunow; W Reutter; M Pawlita
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

5.  Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine.

Authors:  Peter Chefalo; Yanbin Pan; Nancy Nagy; Zhongwu Guo; Clifford V Harding
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

6.  Elongation of the N-acyl side chain of sialic acids in MDCK II cells inhibits influenza A virus infection.

Authors:  O T Keppler; M Herrmann; C W von der Lieth; P Stehling; W Reutter; M Pawlita
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

7.  Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors.

Authors:  H Kayser; R Zeitler; C Kannicht; D Grunow; R Nuck; W Reutter
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

8.  Metabolic installation of thiols into sialic acid modulates adhesion and stem cell biology.

Authors:  Srinivasa-Gopalan Sampathkumar; Adrienne V Li; Mark B Jones; Zhonghui Sun; Kevin J Yarema
Journal:  Nat Chem Biol       Date:  2006-02-12       Impact factor: 15.040

9.  Metabolic delivery of ketone groups to sialic acid residues. Application To cell surface glycoform engineering.

Authors:  K J Yarema; L K Mahal; R E Bruehl; E C Rodriguez; C R Bertozzi
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

10.  Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor.

Authors:  C Schmidt; P Stehling; J Schnitzer; W Reutter; R Horstkorte
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  15 in total

Review 1.  Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

Authors:  Christopher T Saeui; Esteban Urias; Lingshu Liu; Mohit P Mathew; Kevin J Yarema
Journal:  Glycoconj J       Date:  2015-05-01       Impact factor: 2.916

Review 2.  Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Authors:  Haitham A Badr; Dina M M AlSadek; Motawa E El-Houseini; Christopher T Saeui; Mohit P Mathew; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

3.  Modulation of cellular adhesion by glycoengineering.

Authors:  Laila Dafik; Marc d'Alarcao; Krishna Kumar
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

Review 4.  Metabolic oligosaccharide engineering: implications for selectin-mediated adhesion and leukocyte extravasation.

Authors:  Ruben T Almaraz; Mohit P Mathew; Elaine Tan; Kevin J Yarema
Journal:  Ann Biomed Eng       Date:  2011-10-30       Impact factor: 3.934

5.  Sialidases as regulators of bioengineered cellular surfaces.

Authors:  Cristina Y Zamora; Matthew J Ryan; Marc d'Alarcao; Krishna Kumar
Journal:  Glycobiology       Date:  2015-03-20       Impact factor: 4.313

6.  Metabolic monosaccharides altered cell responses to anticancer drugs.

Authors:  Long Chen; Jun F Liang
Journal:  Eur J Pharm Biopharm       Date:  2012-04-02       Impact factor: 5.571

7.  A New Paradigm for Protein Design and Biological Self-Assembly.

Authors:  Gizem Akçay; Krishna Kumar
Journal:  J Fluor Chem       Date:  2009-12-01       Impact factor: 2.050

8.  Photocrosslinking of glycoconjugates using metabolically incorporated diazirine-containing sugars.

Authors:  Michelle R Bond; Haochi Zhang; Peter D Vu; Jennifer J Kohler
Journal:  Nat Protoc       Date:  2009-06-18       Impact factor: 13.491

Review 9.  Metabolic glycoengineering: sialic acid and beyond.

Authors:  Jian Du; M Adam Meledeo; Zhiyun Wang; Hargun S Khanna; Venkata D P Paruchuri; Kevin J Yarema
Journal:  Glycobiology       Date:  2009-08-12       Impact factor: 4.313

10.  Fluorogenic sialic acid glycosides for quantification of sialidase activity upon unnatural substrates.

Authors:  Cristina Y Zamora; Marc d'Alarcao; Krishna Kumar
Journal:  Bioorg Med Chem Lett       Date:  2013-04-10       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.